Download PDF
CC BY-ND-NC 4.0 · SynOpen 2018; 02(02): 0200-0206
DOI: 10.1055/s-0036-1591967
paper
Copyright with the author

Microwave-Assisted Synthesis of Andrographolide Analogues as Potent β-Glycosidase Inhibitors

Masood ur Rahman
a   Organic Chemistry Research Lab, Department of Chemistry, National Institute of Technology, Srinagar, 190006, India
b   Bioorganic Chemistry Division, IIIM, Sanatnagar, Srinagar, 190005, India
,
Iram Ayoob
c   Department of Chemistry, University of Kashmir, Srinagar, 190006, India
,
Shakeel u Rehman
c   Department of Chemistry, University of Kashmir, Srinagar, 190006, India
,
Khursheed A. Bhat
b   Bioorganic Chemistry Division, IIIM, Sanatnagar, Srinagar, 190005, India
,
Tabassum Ara*
a   Organic Chemistry Research Lab, Department of Chemistry, National Institute of Technology, Srinagar, 190006, India
› Author AffiliationsM.R. is grateful to MHRD for providing a research fellowship
Further Information

Publication History

Received: 31 December 2017

Accepted after revision: 04 March 2018

Publication Date:
13 June 2018 (online)

   Permissions and Reprints All articles of this category


Abstract

Andrographolide, a bioactive compound isolated from Andrographis paniculata exhibits multiple pharmacological activities, including anti-HIV, antiplatelet aggregation, hepatic lipid peroxidation protective, hepatoprotective, choleretic, and anticancer effects. Herein, we report the synthesis of diverse analogues of andrographolide along with their β-glucosidase inhibitory activity against sweet almond β-glucosidase. The parent compound, And-1, displayed moderate inhibitory activity against the sweet almond β-glucosidase with IC50 of 142.5 μM. Among the synthesised analogues And-10 showed the best activity, with IC50 of 92.4 μM, whereas the oxidised products (And-4 and And-5) were moderately active against the tested enzyme. Additionally, compounds And-6, And-7, And-8, and And-10 exhibited better β-glucosidase inhibitory activity than the positive control Castanospermine, with IC50 of 100.2, 102.4, 106.5, and 92.4 μM, respectively. These results highlight the importance of an electron-withdrawing NO2 group on the phenyl moiety in attaining the better β-glucosidase inhibition. It is noteworthy that the effect of a particular group plays a significant role in bioactivity. This study thus highlights an important aspect with regard to the most active compounds, which could extend the arsenal of compounds affecting the corresponding enzymes after further polishing and fine tuning.

Key words

andrographolide - β-glucosidase - sweet almond - Castanospermine

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/s-0036-1591967.
  • Supporting Information
 

  • References

  • 1 Dhiman A. Goyal Ju. Sharma K. Nanda A. Dhiman S. J. Pharm. Sci. Innov. 2012; 1: 1
  • 2 Puri A. Saxena R. Saxena RP. Saxena KC. Srivastava V. Tandon JS. J. Nat. Prod. 1993; 56: 995
    CrossrefPubMed
  • 3 Singha PK. Roy S. Dey S. Fitoterapia 2003; 74: 692
    CrossrefPubMed
  • 4 Shen YC. Chen CF. Chiou WF. Br. J. Pharmacol. 2002; 135: 399
    CrossrefPubMed
  • 5 Zhang CY. Tan BK. Clin. Exp. Pharmacol. Physiol. 1996; 23: 675
    CrossrefPubMed
  • 6 Yu BC. Hung CR. Chen WC. Planta Med. 2003; 69: 1075
    Article in Thieme ConnectPubMed
  • 7 Borhanuddin M. Shamsuzzoha M. Hussain AH. Bangladesh Med. Res. Counc. Bull. 1994; 20: 24
    PubMed
  • 8 Wang DW. Zhao HY. Chin. Med. J. (Engl.) 1994; 107: 464
    PubMed
  • 9 Dua VK. Ojha VP. Roy R. J. Ethnopharmacol. 2002; 95: 247
  • 10 Calabrese C. Berman SH. Babish JG. Phytother. Res. 2000; 14: 333
    CrossrefPubMed
  • 11 Amroyan E. Gabrielian E. Panossian A. Phytomedicine 1999; 6: 27
    CrossrefPubMed
  • 12 Choudhury BR. Poddar MK. Methods Find Exp Clin Pharmacol. 1984; 6: 481
    PubMed
  • 13 Handa SS. Sharma A. Indian J. Med. Res. 1990; 92: 284
    PubMed
  • 14 Shukla B. Visen PK. Patnaik GK. Dhawan BN. Planta Med. 1992; 58: 146
    Article in Thieme ConnectPubMed
  • 15 Kumar RA. Sridevi K. Kumar NV. J. Ethnopharmacol. 2004; 92: 291
    CrossrefPubMed
  • 16 Rajagopal S. Kumar RA. Deevi DS. J. Exp. Ther. Oncol. 2003; 3: 147
    CrossrefPubMed
  • 17 Chang HM. Volume 2; World Scientific Publishing Co. Ptd. Ltd., Singapore. 1987: p. 918
    Google Scholar
  • 18 Shen YC. Chen CF. Chiou WF. Planta Med. 2000; 66: 314
    Article in Thieme ConnectPubMed
  • 19 Shen YC. Chen CF. Chiou WF. Br. J. Pharmacol. 2002; 135: 399
    CrossrefPubMed
  • 20 Iruretagoyena MI. Sepulveda SE. Lezana JP. Hermoso M. Bronfman M. Gutierrez MA. Jacobelli SH. Kalergis AM. J. Pharmacol. Exp. Ther. 2006; 318: 59
    CrossrefPubMed
  • 21 Iruretagoyena MI. Tobar JA. Gonzalez PA. Sepulveda SE. Figueroa CA. Burgos RA. Hancke JL. Kalergis AM. J. Pharmacol. Exp. Ther. 2005; 312: 366
    CrossrefPubMed
  • 22 Carretta MD. Alarcon P. Jara E. Solis L. Hancke JL. Concha II. Hidalgo MA. Burgos RA. Eur. J. Pharmacol. 2009; 602: 413
    CrossrefPubMed
  • 23 Burgos RA. Seguel K. Perez M. Meneses A. Ortega M. Guarda MI. Loaiza A. Hancke JL. Planta Med. 2005; 71: 429
    Article in Thieme ConnectPubMed
  • 24 Pratheeshkumar P. Kuttan G. J. Environ. Pathol. Toxicol. Oncol. 2011; 30: 33
    CrossrefPubMed
  • 25 Chen JH. Hsiao G. Lee AR. Wu CC. Yen MH. Biochem. Pharmacol. 2004; 67: 1337
    CrossrefPubMed
  • 26 Yan J. Chen Y. He C. Yang ZZ. Lu C. Chen XS. Cell Biol. Toxicol. 2012; 28: 47
    CrossrefPubMed
  • 27 Bernack RJ. Niedbala MJ. Korytnyk W. Cancer Metastasis Rev. 1985; 4: 81
    CrossrefPubMed
  • 28 Pili R. Chang J. Partis RA. Mueller RA. Chrest FJ. Passaniti A. Cancer Res. 1995; 55: 2920
    PubMed
  • 29 Humphries MJ. Matsumoto K. White SL. Olden K. Cancer Res. 1986; 46: 5215
    PubMed
  • 30 Papandreou MJ. Barbouche R. Guieu R. Kieny MP. Fenouillet E. Mol. Pharmacol. 2002; 61: 186
    CrossrefPubMed
  • 31 Ouzounov S. Mehta A. Dwek RA. Block TM. Jordan R. Antiviral Res. 2002; 55: 425
    CrossrefPubMed
  • 32 Schnidt DD. Frommer W. Junge B. Muller L. Wingender W. Truschei E. Schafer D. Naturwissenschaften 1977; 64: 535
    CrossrefPubMed
  • 33 Kameda Y. Asano N. Yoshikawa M. Takeucki M. Yamaguchi T. Matsui K. Horii S. Fukase H. J. Antibiot. 1984; 37: 1301
    CrossrefPubMed
  • 34 Robinson KM. Begovic ME. Rhinehart BL. Heineke EW. Ducep JB. Kastner PR. Marshall FN. Danzin C. Diabetes 1991; 40: 825
    CrossrefPubMed
  • 35 Fujisawa T. Ikegami H. Inoue K. Kawabata Y. Ogihara T. Metabolism 2005; 54: 387
    CrossrefPubMed
  • 36 Van den Broek LA. Kat-Van Den Nieuwenhof MW. Butters TD. Van Boeckel CA. J. Pharm. Pharmacol. 1996; 48: 172
    CrossrefPubMed
  • 37 Zhang XF. Tan BK. Clin. Exp. Pharmacol. Physiol. 2000; 2: 358
  • 38 Zhang XF. Tan BK. Acta Pharmacol. Sin. 2000; 21: 1157
    PubMed
  • 39 Rafidah H. Azimahtol HP. Meenakshii N. J. Ethnopharmacol. 2004; 95: 205
    CrossrefPubMed
  • 40 Siripong P. Kongkathip B. Preechanukool K. Picha P. Tunsuwan K. Taylor WC. J. Sci. Soc. Thailand 1992; 18: 187
    Crossref
  • 41 Sambyal VS. Goswami KN. Cryst. Res. Technol. 1995; 30: 629
    Crossref
  • 42 Yong JK. Akira T. Naoto K. Takeshi K. Tetrahedron 1999; 55: 8353
    Crossref
  • 43 Wu CY. Hsu CC. Tsai YC. Biochem. Biophys. Res. Commun. 2001; 284: 466
    CrossrefPubMed
  • 44 Verma N. Behera BC. Sharma BO. Hacettepe J. Biol. Chem. 2012; 40: 7
  • 45 Ani V. Naidu KA. Eur. Food Res. Technol. 2008; 226: 897
    Crossref
  • 46 Rupercht RM. Mullaney S. Andersen J. Bronson R. J. Acquired Immune Defic. Syndr. 1989; 2: 149
  • 47 Shakeel-u-Rehman, Bhat KA. Lone SH. Malik FA. Arabian J. Chem. 2015; DOI: 10.1016/j.arabjc.2015.10.009.
    Crossref
  • 48 Ayoob I. Lone SH. Masood-ur-Rahman, Zargar OA. Bashir R. Shakeel-u-Rehman, Khuroo MA. Bhat KA. ChemistrySelect 2017; 2: 10153
    Crossref